市場調査レポート
商品コード
1138303
骨伝導型補聴器の世界市場-2022-2029Global Bone Anchored Hearing Aids Market - 2022-2029 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
骨伝導型補聴器の世界市場-2022-2029 |
出版日: 2022年10月18日
発行: DataM Intelligence
ページ情報: 英文 170 Pages
納期: 約2営業日
|
高齢化と小児における難聴の増加が、市場成長の主な要因の1つとなっています。
世界保健機関によると、難聴者の多くは成人、特に70歳以上の高齢者です。世界人口の5%以上にあたる約4億6600万人が難聴者であり、そのうち約4億3200万人が成人、残りの3400万人が小児となっています。2050年末には、9億人以上の人が難聴になると予想されています。65歳以上の人の30%以上が難聴に苦しんでいます。また、世界の高齢者人口も大幅に増加しており、聴覚障害が増加し、BAHAの需要をさらに促進しています。さらに、子供の聴覚障害の増加も、この人口動態における市場参加者に十分な機会を提供しています。12歳から35歳の約11億人の若者は、レクリエーションの場で騒音に接することにより、難聴になるリスクが高いとされています。
また、ロボット工学の採用が増えれば、手術の合併症を大幅に減らすことができるため、製品需要がさらに高まります。手術用ナビゲーションシステムは、耳の外科医の視覚を改善し、骨伝導型補聴器を埋め込む際の人的ミスを低減します。したがって、市場のサプライヤーは、製品の消費を拡大するために、強化された手術用ナビゲーションシステムとロボットプラットフォームの開発を目指しています。これらのロボットシステムの利点は、かなり耳鼻咽喉科治療を行う病院や外科医の間でその需要を強化し、したがって、今後数年間で市場の拡大を増殖させると思われます。人工内耳、補聴器、聴覚脳幹インプラントなどの優れた代替品が、製品需要の妨げになると予想されます。
また、皮膚刺激、オッセオ統合の失敗、慢性感染などの製品の副作用は、レビュー期間中の市場成長をさらに妨げます。
骨伝導補聴器の世界市場レポートでは、約76の市場データ表、58の図、170ページへのアクセスを提供します。
The Bone anchored hearing aids market was valued at USD 226.9 million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 7.89% during the forecast period (2022-2029).
A bone-anchored hearing aid (BAHA) is a surgical hearing device based on a conduction mechanism that helps patients suffering from hearing loss with vibrations. It is used to treat various hearing loss types, including single-sided deafness, chronic ear infections, and acoustic neuroma. Hearing losses mainly occur when sound is unable to reach the inner ear. In BAHA, a steel spring is attached over the person's head that gathers the sound waves as a traditional hearing aid, but instead of transmitting sound waves, it transfers vibrations to the inner ear through the skull bone. These hearing aids typically use a titanium alloy implant surgically implanted on the skull. The global bone anchored hearing aids market growth is mainly driven by the rising prevalence of hearing losses among the geriatric and pediatric populations globally, thus augments the industry expansion.
Market Dynamics: The increasing prevalence of hearing loss in the ageing and pediatric population is one of the prime factors proliferating the market growth.
According to World Health Organization, most people with hearing loss are adults, particularly those aged 70 years and above. More than 5% of the world's population, around 466 million people, has disabling hearing loss, of which about 432 million are adults and the remaining 34 million children. It is expected that by the end of 2050, more than 900 million people will suffer from disabling hearing loss. Over 30% of people over 65 are affected by disabling hearing loss. The global geriatric population is also growing significantly, increasing hearing impairment and further promulgating the demand for BAHA. Moreover, the growing prevalence of hearing impairment in children provides ample opportunities for the market players in this demography. Around 1.10 billion young people aged between 12-35 are at a high risk of hearing loss due to acquaintance with noise in recreational settings.
Moreover, the increased adoption of robotics can substantially reduce surgical complications, further driving product demand. The surgical navigation systems improve ear surgeons' visuals, resulting in lower human error while implanting bone-anchored hearing aids. Therefore, market suppliers aim to develop enhanced surgical navigation systems and robotic platforms to expand product consumption. These robotic systems' benefits will considerably bolster their demand among the hospitals and surgeons performing ENT treatments, thus proliferating the market expansion in the coming years. Good substitutes such as cochlear implants, hearing aids, and auditory brain stem implants are expected to hinder product demand.
Adversely, side effects of the product, such as skin irritation, failure of Osseo integration, and chronic infection, further hamper the market growth during the review period.
Market Segmentation: Titanium material segment accounted for the highest share in global bone anchored hearing aids market.
A bone-anchored hearing aid is a bone transmission hearing aid consisting of a titanium fixture permanently implanted into the skull's mastoid bone and an external percutaneous sound processor. The titanium-based implant is likely to last a lifetime. It is an ideal implant material. Medical-grade titanium exhibits unmatched strength when compared to other hearing aids. It can easily withstand more wear and tear as it won't crack or break, or get damaged easily. Besides, it is bio-acceptable with good hearing results. Moreover, it offers a better acoustic advantage due to its mechanical stiffness and low weight.
Based on the hearing loss type, the bone-anchored hearing aids market is classified into sensorineural hearing loss, mixed hearing loss, conductive hearing loss, and single-sided deafness. The conductive hearing loss end user is likely to garner the largest market share in the coming years. Conductive hearing loss is a prevalent type of hearing loss. Patients with this hearing impairment are generally fitted with either traditional air or bone conduction hearing aids. Although difficulties mainly arise when hearing loss is further complicated by chronic suppurative otitis media or otitis externa. In such situations, an ear mould is difficult to use. Some patients with bilateral conductive hearing losses who have complicating hearing issues such as canal atresia, mastoid cavities, or revision ossiculoplasty are crucial sources of frustration for all involved in their care. In these patients, the introduction of BAHA has been beneficial in helping with conductive hearing loss.
Based on end-user, the bone-anchored hearing aids market has been classified into pediatrics, adults, and geriatrics. The adult segment is anticipated to hold the largest market share in the bone-anchored hearing aids market during the review period. The adult segment is the major end-user of bone-anchored hearing aids due to the rising prevalence of hearing loss among adults worldwide.
Geographical Penetration: North America is the dominating region during the forecast period.
North America held the largest share in the global bone-anchored hearing aids market due to advanced and modern medical infrastructure & facilities coupled with high healthcare expenditure. Moreover, the easy availability of medical insurance and reimbursement facilities offered by Canada and the U.S. are expected to propel the demand for BAHA in the coming years. According to National Institute on deafness and other communication disorders, one in eight people in the U.S., around 13% or 30 million people aged 12 years and above, has hearing loss in both ears. Also, around 2% of adults aged 45 to 54 suffer from disabling hearing loss.
The European market is expected to account for a substantial market share in the following years due to an increasing inclination towards advanced hearing tools. Also, the prevalence of a large geriatric population in countries like Italy and Germany further drives the demand for BAHA. The presence of key vendors, growing awareness about the benefits of bone-anchored hearing aid prosthetics, and regulatory approvals augment European market growth. Vendors mainly focus on ramping up their sales in Western Europe through business strategies such as direct-to-consumer marketing and expanded field sales organization.
The bone-anchored hearing aids market is moderately competitive with the presence of regional and global players. Some key players contributing to the market's growth include AUDITDATA, Cochlear Limited, MED-EL Medical Electronics, Natus Medical Incorporated, Sivantos Group, Sonova Holding AG, and Advanced Bionics Corporation, among others. The major players are adopting several growth strategies, such as product launches, collaborations, and expansion, contributing to the growth of the bone-anchored hearing aids market globally. In March 2021, Cochlear Limited received FDA clearance for Baha 6 Max product. It is one of the smallest 55 dB sound processors with direct android streaming. Cochlear Limited is the global leader in implantable hearing solutions. This device has noise and feedback reduction features with a frequency range of 9.7 kHz. In March 2022, Sonova completes the acquisition of the Sennheiser Consumer Division and forms a new business. This acquisition creates growth opportunities in the fast-growing market for true wireless headsets, the emerging segment of speech-enhanced hearable, and expands Sennheiser's strong position in audiophile headphones. As part of the acquisition, the company has secured a perpetual license for the Sennheiser brand, under which all new consumer hearing devices are marketed.
COVID-19 Impact: Positive impact on the global bone anchored hearing aids market
COVID-19 has put considerable pressure on the healthcare and medical devices sector because of the increasing number of patients suffering from respiratory and other chronic diseases. The measures taken to reduce the coronavirus's spread during the pandemic have adversely affected patients' living conditions suffering from hearing loss without COVID-19 infection. The growing use of masks to curb coronavirus spread has led to decreased sound transmission and intelligibility. Besides, the lack of lip movements due to the facial mask is expected to increase the understanding of individuals with hearing impairment as these individuals highly depend on lip movements. Thus, these factors are mainly responsible for expanding hearing aids, such as bone-anchored hearing aids with hearing loss during the forecast timeline.
The global bone anchored hearing aids market report would provide an access to approximately 76 market data tables, 58 figures and 170 pages
Scope and Methodology